EP Patent

EP1134222A1 — IMIDAZO[4,5-b]PYRIDINIUMMETHYL-CONTAINING CEPHEM COMPOUNDS HAVING BROAD ANTIBACTERIAL SPECTRUM

Assigned to Shionogi and Co Ltd · Expires 2001-09-19 · 25y expired

What this patent protects

A cefem compound of the formula (I) shows wide antibacterial spectrum against various pathogenic bacteria including MRSA. wherein, X is N or CY and Y is H or halogen; R 1 is amino or protected amino; R 2 is hydrogen or optionally substituted lower alkyl etc.; R 3 is hydrogen…

USPTO Abstract

A cefem compound of the formula (I) shows wide antibacterial spectrum against various pathogenic bacteria including MRSA. wherein, X is N or CY and Y is H or halogen; R 1 is amino or protected amino; R 2 is hydrogen or optionally substituted lower alkyl etc.; R 3 is hydrogen etc.; R 4 is hydrogen, optionally substituted lower alkyl, or optionally substituted N-containing heterocyclic group etc.; R 5 is hydrogen etc.; and a wavy line means syn- or anti-isomerism or a mixture thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP1134222A1
Jurisdiction
EP
Classification
Expires
2001-09-19
Drug substance claim
No
Drug product claim
No
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.